Abstract
HSP70 is a molecular chaperone and a key component of the heat-shock response. Because of its proposed importance in oncology, this protein has become a popular target for drug discovery, efforts which have as yet brought little success. This study demonstrates that adenosine-derived HSP70 inhibitors potentially bind to the protein with a novel mechanism of action, the stabilization by desolvation of an intramolecular salt-bridge which induces a conformational change in the protein, leading to high affinity ligands. We also demonstrate that through the application of this mechanism, adenosine-derived HSP70 inhibitors can be optimized in a rational manner.
| Original language | English |
|---|---|
| Pages (from-to) | 4625-4636 |
| Number of pages | 12 |
| Journal | Journal of Medicinal Chemistry |
| Volume | 59 |
| Issue number | 10 |
| Early online date | 27 Apr 2016 |
| DOIs | |
| Publication status | Published - 26 May 2016 |
Fingerprint
Dive into the research topics of 'Exploiting protein conformational change to optimize adenosine-derived inhibitors of HSP70'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver